CoChat

Fecal microbiota transplantation is a rescue treatment modality for refractory ulcerative colitis

Open access
Uygun, Ahmet, Ozturk, Kadir, Demirci, Hakan, Oger, Cem, Avci, Ismail Yasar, Turker, Turker, Gulsen, Mustafa · 2017 · Medicine
Cited by 58

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Fecal microbial transplantation (FMT) provides to replace beneficial bacteria with more favorable microbiomes in recipient with dysbiosis. The aim of the present study was to prospectively investigate the efficacy of FMT by assessing the clinical and endoscopic response in patients with ulcerative colitis (UC) who had failed anti-inflammatory and immunosuppressive therapy. METHODS: In this prospective and uncontrolled study, 30 patients with UC were included. All medications except mesalazine were stopped 4 weeks before FMT. Colonoscopy was performed both before and after FMT. To assess the efficacy of FMT, Mayo scores were calculated at week 0 and week 12. A total of 500 mL extracted fresh fecal suspension was administered into the 30 to 40 cm proximal of terminal ileum of recipients. RESULTS: After FMT, 21 of the (70%) 30 patients showed clinical response, and 13 of the 30 (43.3%) patients achieved clinical and endoscopic remission at the week 12. Nine patients (30%) were accepted as a nonresponder at the end of the week 12. There was no significant difference among donors concerning both the rate of clinical remission and clinical response. No adverse events were observed in the majority of patients during FMT and 12 weeks follow-up. Seven patients (23.3%) experienced mild adverse events such as nausea, vomiting, abdominal pain, diarrhea, and fewer after FMT. CONCLUSION: FMT could be considered as a promising rescue treatment modality before surgery in patients with refractory UC. Besides, FMT also appears to be definitely safer and more tolerable than the immunosuppressive therapy in patients with UC (NCT02575040).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/md.0000000000006479

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Research works printed but not linked: 18

  1. Loftus, 2004, Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences, Gastroenterology, 126, 1504, 10.1053/j.gastro.2004.01.063 · DOI · Paper page
  2. Serban, 2015, Microbiota in inflammatory bowel disease pathogenesis and therapy: is it all about diet?, Nutr Clin Pract, 30, 760, 10.1177/0884533615606898 · DOI · Paper page
  3. Danese, 2011, Ulcerative colitis, N Engl J Med, 365, 1713, 10.1056/NEJMra1102942 · DOI · Paper page
  4. Girotra, 2016, Fecal microbiota transplantation for recurrent Clostridium difficile infection in the elderly: long-term outcomes and microbiota changes, Dig Dis Sci, 61, 3007, 10.1007/s10620-016-4229-8 · DOI
  5. Paramsothy, 2016, Multi-donor intense faecal microbiota transplantation is an effective treatment for resistant ulcerative colitis: a randomised placebo-controlled trial, J Crohns Colitis, 10, S14
  6. Silverberg, 2005, Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology, Can J Gastroenterol, 19, 5A, 10.1155/2005/269076 · DOI · Paper page
  7. Cammarota, 2016, Principles of DNA-based gut microbiota assessment and therapeutic efficacy of fecal microbiota transplantation in gastrointestinal diseases, Dig Dis, 34, 279, 10.1159/000443362 · DOI · Paper page
  8. Britton, 2014, Role of the intestinal microbiota in resistance to colonization by Clostridium difficile, Gastroenterology, 146, 1547, 10.1053/j.gastro.2014.01.059 · DOI · Paper page
  9. Sun, 2016, Fecal microbiota transplantation as a novel therapy for ulcerative colitis: a systematic review and meta-analysis, Medicine (Baltimore, 95, e3765, 10.1097/MD.0000000000003765 · DOI
  10. Shi, 2016, Fecal microbiota transplantation for ulcerative colitis: a systematic review and meta-analysis, PLoS One, 11, e0157259, 10.1371/journal.pone.0157259 · DOI · Paper page
  11. Scaldaferri, 2016, Efficacy and mechanisms of action of fecal microbiota transplantation in ulcerative colitis: pitfalls and promises from a first meta-analysis, Transplant Proc, 48, 402, 10.1016/j.transproceed.2015.12.040 · DOI
  12. Kump, 2016, Any future for fecal microbiota transplantation as treatment strategy for inflammatory bowel diseases?, Dig Dis, 34, 74, 10.1159/000447379 · DOI
  13. Xu, 2016, Clinical efficacy maintains patients’ positive attitudes toward fecal microbiota transplantation, Medicine (Baltimore, 95, e4055, 10.1097/MD.0000000000004055 · DOI
  14. Damman, 2015, Low level engraftment and improvement following a single colonoscopic administration of fecal microbiotato patients with ulcerative colitis, PLoS One, 10, e0133925, 10.1371/journal.pone.0133925 · DOI · Paper page
  15. Kahn, 2013, Patient perceptions of fecal microbiota transplantation for ulcerative colitis, Inflamm Bowel Dis, 19, 1506, 10.1097/MIB.0b013e318281f520 · DOI · Paper page
  16. Zhang, 2016, Short-term surveillance of cytokines and C-reactive protein cannot predict efficacy of fecal microbiota transplantation for ulcerative colitis, PLoS One, 11, e0158227, 10.1371/journal.pone.0158227 · DOI · Paper page
  17. Peyrin-Biroulet, 2014, Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial, Gut, 63, 88, 10.1136/gutjnl-2013-304984 · DOI · Paper page
  18. Reinisch, 2012, C-reactive protein, an indicator for maintained response or remission to infliximab in patients with Crohn's disease: a post-hoc analysis from ACCENT I, Aliment Pharmacol Ther, 35, 568, 10.1111/j.1365-2036.2011.04987.x · DOI · Paper page

Cited by

See all 58

Metadata

Authors
Uygun, A., Ozturk, K., Demirci, H., Oger, C., Avci, I. Y., Turker, T., & Gulsen, M.
Venue
Medicine
Published
2017-04
Volume
96
Issue
16
Pages
e6479
ISSN
0025-7974 (ISSN-L)
OpenAlex
W2606047789
Cited by
58
References
8
FWCI
5.24
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Fecal microbiota transplantation is a rescue treatment modality for refractory ulcerative colitis. https://app.cochat.ai/papers/10.1097/md.0000000000006479
The paper
Uygun, A., Ozturk, K., Demirci, H., Oger, C., Avci, I. Y., Turker, T., & Gulsen, M. (2017). Fecal microbiota transplantation is a rescue treatment modality for refractory ulcerative colitis. Medicine. https://doi.org/10.1097/md.0000000000006479

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.